Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Irinotecan, 5-FU/Leucovorin, Oxaliplatin, and Adebrelimab + Radiotherapy for Pancreatic Cancer
NCT07542002Phase 2Recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Mar 2025
- Primary completion
- May 2026
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of adebrelimab in pancreatic cancer (PC), sponsored by Ningbo Medical Centre Lihuili Hospital. Started Mar 2025; status: recruiting.
02
Drugs
adebrelimab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07542002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07542002.